Two years after a push for more transparency in the costs of insulin for diabetes treatment, state Sen. Yvanna Cancela is hoping to shed even more light on prescription drug prices and the health care system in Nevada
2019 Legislature
MOST READ: POLITICS & GOVT
1
2
3
4
5
Trump’s betting odds to win election take hit after conviction
Nevada to see increase in state’s minimum wage
As extreme heat kills more Nevadans, OSHA bets on worker protections
Meet the businessman who got Clark County’s first sidewalk vending license
Clark County DA says judge is biased, should be removed from all criminal cases